1. Skip to Menu
  2. Skip to Content
  3. Skip to Footer>

Our Blog

Direct Radiography to Drive Growth of Radiology Market in Europe

PDFPrintE-mail

 Hospital Radiology Census 2010 for Europe

LEIPZIG, GERMANY – (HealthTech Wire / News) – data information intelligence (DII) announces today the first results of the Hospital Radiology Census 2010 for Europe. According to the Germany-based analyst, investments into X-Ray systems in European markets are expected to grow further and demand for direct radiography systems will rise significantly. Computed radiography will reach saturation levels in many European markets. DII will present details of the Hospital Radiology Census 2010 to US audiences during a webinar on December 15, 2010.

Read Article

 

Chemical-Free Body Wash From Annmarie Skin Care Cleans Naturally

PDFPrintE-mail

 Uplifting and Eye-Opening!

Annmarie Gianni Skin Care’s new Rosemary/Peppermint Body Wash is a pH balanced, antimicrobial and hydrating new addition to the award-winning chemical-free skin care line.

Founded in 2010, Annmarie Gianni Skin Care broke into the skin care industry with an impressive product line that is free from harsh chemicals, parabens, and other additives that can be stripping and even damaging to delicate areas of the skin’s surface.

Read Article

 

BERCHTOLD’s New OPERON D 760 High-Tech OR-Table

PDFPrintE-mail

 Versatile, with premium construction and high capacity, the OPERON D 760 OR-Table guarantees ideal working conditions in the operating theatre with an extensive range of accessories and various mutually compatible leg plates. The surgeon can adjust the new OR-Table height by 440 mm for ergonomic working. Patients can be positioned flexibly on a surface of four modules. The table can support extremely obese patients weighing up to 450 kg.

Read Article

 

BioCer Introduce Latest Plant-based Hemostasis and Coated Hernia Repair Technologies to China

PDFPrintE-mail

 HaemoCer(TM) an Absorbable Polysaccharide Hemostat (APH) and Ti0(2)Mesh(TM) Hernia Repair System

BioCer Entwicklungs GmbH, a Bayreuth, Germany based medical device manufacturer, are pleased to announce their attendance at the China Medical Equipment Fair (CMEF) Shenzhen, China 15th-19th April 2011. HaemoCer(TM) an Absorbable Polysaccharide Hemostat (APH) and Ti0(2)Mesh(TM) Hernia repair system will be on exhibit at the BioCer booth.

Read Article

 

People with Severe Mental Illness Twelve Times More Likely to Commit Suicide

PDFPrintE-mail

 People with psychotic disorders, such as schizophrenia or bipolar disorder, are 12 times more likely to commit suicide than average, according to research released today by King’s Health Partners.

The research found that the rate of suicide was highest in the first year following diagnosis (12 times national average) and that high risk persisted ­ remaining four times greater than the general population ten years after diagnosis, a time when there may be less intense clinical monitoring of risk.

Read Article

 

Ground-Breaking Technology will Revolutionise Blood Pressure Measurement for First Time for Over a Century

PDFPrintE-mail

 Pioneering New Technology will Lead to Better Treatment Decisions and Better Outcomes for Patients

In a major scientific breakthrough, a new blood pressure measurement device is set to revolutionise the way patients’ blood pressure is measured. The new approach, invented by scientists at the University of Leicester and in Singapore, has the potential to enable doctors to treat their patients more effectively because it gives a more accurate reading than the current method used. It does this by measuring the pressure close to the heart ­ the central aortic systolic pressure or CASP.

Read Article

 

Alere Introduces the World’s First Fingerstick BNP Test

PDFPrintE-mail

 Alere has launched the World’s first fingerstick BNP (b-typenatriuretic peptide) test as an aid indiagnosis and assessment of severity of patients with heart failure. Providing rapid point of care BNP results to aid healthcare professionals in their decision making process, the compact BNP analyser provides lab accurate results within 15 minutes from a 12μl
capillary blood sample. The new Alere™ Heart Check System is designed to aid in the diagnosis of heart failure, assess the severity of heart failure, and enable risk stratification of patients with heart failure as well as those with acute coronary syndromes.

Read Article

 

Point-of-Sale Electronic Safety Check May Reduce Heart Attack Risk for Diabetic Patients

PDFPrintE-mail

 Program Flags Insulin or Nitrate Use for Patients Filling Avandia Prescriptions

According to a new pharmacy benefit study, a point-of-sale automated electronic safety edit, designed to require provider prior authorization (PA) for members who have a rosiglitazone claim with concurrent use of insulin or nitrate (CIN), potentially decreased members’ risk for myocardial ischemia. The study will be presented at the Academy of Managed Care Pharmacy’s 23rd Annual Meeting in Minneapolis, Minn. by Prime Therapeutics (Prime), a thought leader in pharmacy benefit management.

Read Article

 

Ground-breaking Technology will Revolutionise Blood Pressure Measurement for First Time for over a Century

PDFPrintE-mail

  Pioneering new technology will lead to better treatment decisions and better outcomes for patients

In a major scientific breakthrough, a new blood pressure measurement device is set to revolutionise the way patients’ blood pressure is measured. The new approach, invented by scientists at the University of Leicester and in Singapore, has the potential to enable doctors to treat their patients more effectively because it gives a more accurate reading than the current method used. It does this by measuring the pressure close to the heart ­ the central aortic systolic pressure or CASP.

Read Article

 

Brainlab and SurgiVision Announce Strategic Alliance in MRI-Guided Drug Delivery and Other Interventional MRI Technologies in Neurosurgery

PDFPrintE-mail

 Brainlab AG and SurgiVision, Inc. has announced a collaboration aimed at integrating SurgiVision’s ClearPoint® product line with Brainlab’s iMRI product line

With particular focus on local delivery of drugs and other therapeutic agents to precision targets in the brain under magnetic resonance imaging (MRI) guidance,Brainlab and SurgiVision believe the integration of their technologies will allow patient-specific treatment planning, simplified clinical workflows and optimal delivery of drugs to the brain.

Read Article

 

Page 8 of 23

Featured Exhibitions

Featured Advertisers

 

 cardiacsci.jpg - 2.83 Kb
sonoscape.jpg 
varian.gif
aneticaid_1.gif